Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in GPCR — Structure Therapeutics Inc.

CIK 1214717 BOSTON, MA
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$5,215,811
+$1,944,863 QoQ
Shares Held
97,183
+43.2% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 190 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. GPCR ranks #236 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in GPCR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,215,811 97,183
2026-03-31 $3,270,948 67,862
2025-12-31 $3,835,543 55,148
2025-09-30 $1,622,824 57,958
2025-06-30 $1,123,713 54,181
2025-03-31 $791,707 45,737
2024-12-31 $1,239,519 45,705
2024-09-30 $1,984,925 45,225
2024-06-30 $1,763,733 44,913
2024-03-31 $1,238,482 28,896
2023-12-31 $904,627 22,194
2023-09-30 $392,822 7,791
2023-06-30 $426,383 10,257